International Society for the Study of Women's Sexual Health

Bulletin Board

Controversies in Women's Health Course Information

Mayo Clinic Controversies in Women’s Health Course
June 15-17 2017
Westin Chicago River North, Chicago, IL

Controversies in Women’s Health will assist health care providers improve care of female patients based on emerging scientific and clinical evidence related to medical conditions that are unique to women, occur more frequently in women or present differently in women. The course includes presentations from key women's health specialty and subspecialty disciplines including obstetrics and gynecology, reproductive medicine, sexual health, menopausal medicine, cardiology, endocrinology, internal medicine and preventive medicine.

Following completion of this course, participants should be able to:
  • Summarize breast cancer risk assessment strategies and screening controversies
  • Implement effective strategies for the care of the transgender patient
  • Discuss individualized approaches to management of pelvic pain
  • Describe a personalized approach to the use of menopausal hormone therapy

Visit Website

Download Brochure Here

Category: CME Programs

Save the Date

ISSWSH Fall Course 2019
November 14-16, 2019   206 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   318 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

Latest Tweets

New studies indicate less risk of flibanserin and alcohol. #addyi #flibanserin @SproutPharma https://t.co/TTnjvQbO9x ISSWSH
New review looking at sexual dysfunction among PCOS (polycystic ovarian syndrome) patients demonstrates that sexual… https://t.co/JuQ7yxxDxE ISSWSH
Suffering from #painfulsex? Read about one patients Journey and evidence based resources. #patientadvocatehttps://t.co/OBSu6FINOh ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!